Showing results (231-240 of 379) with videos related to
Sort By:
Pageof 38
Circulation|December 14, 2021
Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADERAhmed M Shaman, Stephen C Bain, George L Bakris, et al.Kidney International|November 1, 2023
Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathyHong Zhang, Dana V Rizk, Vlado Perkovic, et al.Kidney International Supplements|January 25, 2019
Action plan for optimizing the design of clinical trials in chronic kidney diseaseVlado Perkovic, Jonathan C Craig, Worawon Chailimpamontree, et al.Journal of the American Society of Nephrology : JASN|September 23, 2021
Early Response in Albuminuria and Long-Term Kidney Protection during Treatment with an Endothelin Receptor Antagonist: A Prespecified Analysis from the SONAR TrialHiddo J L Heerspink, Di Xie, George Bakris, et al.Diabetologia|August 27, 2021
Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA1c, disease duration and treatment intensity: results from the CANVAS ProgramTamara K Young, Jing-Wei Li, Amy Kang, et al.Kidney International|January 11, 2013
Intensive glucose control improves kidney outcomes in patients with type 2 diabetesVlado Perkovic, Hiddo Lambers Heerspink, John Chalmers, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 22, 2016
Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial FibrillationMin Jun, Matthew T James, Zhihai Ma, et al.Clinical Journal of the American Society of Nephrology : CJASN|July 14, 2025
SGLT2 Inhibition and Hospitalizations in Patients with CKD: A Meta-Analysis of Kidney Outcome TrialsMegumi Oshima, Luke Buizen, Niels Jongs, et al.Journal of the American Heart Association|January 19, 2024
Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE TrialAbhinav Sharma, Amir Razaghizad, Abdulaziz Joury, et al.The Medical Journal of Australia|July 27, 2016
Guideline for the diagnosis and management of hypertension in adults - 2016Genevieve M Gabb, Arduino A Mangoni, Craig S Anderson, et al.Pageof 38